John C. King

Corporate Officer/Principal presso VOR BIOPHARMA INC.

49 anni

Health Technology

Consumer Services

Posizioni attive di John C. King

Società	Posizione	Inizio	Fine
VOR BIOPHARMA INC.	Corporate Officer/Principal	01/08/2020	-

Società	Posizione	Inizio	Fine
RA PHARMACEUTICALS, INC.	Corporate Officer/Principal	16/04/2018	01/08/2020
ALEXION PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/01/2014	01/03/2018
ALEXION PHARMACEUTICALS, INC.	Vendite & Marketing	01/01/2012	01/01/2014
Wyeth Pharmaceuticals LLC Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA.	Corporate Officer/Principal	-	-

The Pennsylvania State University

Masters Business Admin

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	4
Sales & Marketing	1
Masters Business Admin	1

Settori

Health Technology	5
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
VOR BIOPHARMA INC.	Health Technology

Aziende private	3
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA.	Health Technology
Ra Pharmaceuticals, Inc. Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA.	Health Technology
Wyeth Pharmaceuticals LLC Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA.	Health Technology